BCI
CRL icon

Brinker Capital Investments’s Charles River Laboratories CRL Stock Holding History

Brinker Capital Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,390
Closed -$257K – 1898
2024
Q4 		$257K Sell
1,390
-1,847
-57% -$356K ﹤0.01% 1629
2024
Q3 		$638K Sell
3,237
-67
-2% -$13.9K 0.01% 1243
2024
Q2 		$683K Sell
3,304
-74
-2% -$16.8K 0.01% 1163
2024
Q1 		$915K Sell
3,378
-38
-1% -$9.07K 0.01% 1026
2023
Q4 		$775K Sell
3,416
-602
-15% -$118K 0.01% 1049
2023
Q3 		$787K Sell
4,018
-560
-12% -$115K 0.01% 1033
2023
Q2 		$963K Sell
4,578
-107
-2% -$21.3K 0.01% 970
2023
Q1 		$946K Sell
4,685
-474
-9% -$107K 0.01% 899
2022
Q4 		$1.12M Sell
5,159
-269
-5% -$58.7K 0.02% 695
2022
Q3 		$1.07M Buy
5,428
+149
+3% +$32.2K 0.02% 682
2022
Q2 		$1.13M Sell
5,279
-632
-11% -$154K 0.02% 689
2022
Q1 		$1.68M Sell
5,911
-261
-4% -$80.5K 0.03% 597
2021
Q4 		$2.33M Buy
6,172
+1,041
+20% +$404K 0.03% 514
2021
Q3 		$1.9M Hold
5,131
– – 0.03% 560
2021
Q2 		$1.9M Sell
5,131
-525
-9% -$175K 0.03% 613
2021
Q1 		$1.64M Sell
5,656
-1,828
-24% -$508K 0.02% 567
2020
Q4 		$1.87M Buy
7,484
+3,379
+82% +$805K 0.03% 567
2020
Q3 		$930K Buy
+4,105
New +$852K 0.02% 708

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brinker Capital Investments's CRL Position: Q1 2025 in Review

Brinker Capital Investments sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 1,390 shares — an estimated $257K sold.

Brinker Capital Investments first reported a position in CRL in Q3 2020 and held it in 18 quarters. The position peaked at $2.33M in Q4 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Brinker Capital Investments reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Brinker Capital Investments sold 1,390 Charles River Laboratories shares in Q1 2025, an estimated $257K.
  • Brinker Capital Investments first reported a position in Charles River Laboratories in Q3 2020 and held it in 18 quarters.
  • Brinker Capital Investments's Charles River Laboratories position peaked at $2.33M in Q4 2021.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Brinker Capital Investments's 13F filing for Q1 2025, filed 1 Aug 2025.